Floxuridine Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 500 mg
Reference Brands: Generic formulations marketed under different names
Category:
Oncology Cancer Care
Floxuridine is available in Injection
and strengths such as 500 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Floxuridine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Floxuridine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Floxuridine, also known as 5-fluorodeoxyuridine, is an antimetabolite chemotherapy agent belonging to the pyrimidine analog class and specifically classified as a deoxyuridine. It is primarily used in oncology for the treatment of colorectal cancer, particularly for patients with liver metastases. Floxuridine is typically administered via hepatic artery infusion, allowing high local concentrations in the liver while minimizing systemic exposure. This targeted delivery has been shown to significantly improve patient quality of life and survival rates compared to standard treatments.
In addition to colorectal cancer, floxuridine may also be prescribed for kidney and stomach cancers under specialized oncology protocols. Its mechanism of action involves incorporation into DNA, inhibiting thymidylate synthase, and disrupting DNA synthesis, ultimately leading to cancer cell death. Beyond clinical applications, floxuridine is used in vitro in research to study cell proliferation, such as in Tenon’s capsule fibroblasts with short-term exposure to fluorouracil, floxuridine, and mitomycin. With its targeted delivery, high efficacy in liver metastases, and versatility in both clinical and research settings, floxuridine remains a key drug in antimetabolite chemotherapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing